kras g12c mutation Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Any (1)

Phase 1 (1)

Interventional (1)

Genentech, Inc. (1)

No (1)

No (1)

Adult (18+) (1)

b (1)
cancer (1)
center (1)
centr (1)
citi (1)
comprehens (1)
dana (1)
davi (1)
farber (1)
florida (1)
gener (1)
hope (1)
hospit (1)
institut (1)
jewish (1)
ketter (1)
maccallum (1)
margaret (1)
memori (1)
mortim (1)
peter (1)
princess (1)
sarasota (1)
sir (1)
sloan (1)
specialist (1)
yale (1)

I am/have/had

I am/have/hadsolid tumor

I am/have/hadkras g12c mutation

I am/have/hadkras

I am/have/hadmetastatic malignant solid tumor

I am/have/hadsolid tumour

added new label for I am/have/had

more

I am looking for

I am looking forkras

I am looking forki-ras

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

solid tumor

kras g12c mutation

kras

metastatic malignant solid tumor

ki-ras

0 views
16 Feb, 2024
8 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.